Showing results (151-160 of 162) with videos related to
Sort By:
Pageof 17
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapyW C Jackson, K Suresh, C Maurino, et al.International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Use of Veff and iso-NTCP in the implementation of dose escalation protocolsR K Ten Haken, M K Martel, M L Kessler, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1991
Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridineT S Lawrence, L M Dworzanin, S C Walker-Andrews, et al.Journal of Magnetic Resonance Imaging : JMRI|January 24, 2009
Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy studyP C Sundgren, V Nagesh, A Elias, et al.Lung Cancer (Amsterdam, Netherlands)|July 14, 1999
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsM K Martel, R K Ten Haken, M B Hazuka, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1990
A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenograftsD J Buchsbaum, R K ten Haken, D B Heidorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancerC J McGinn, M M Zalupski, I Shureiqi, et al.Oncogene|December 6, 2006
Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicityF Y Feng, S Varambally, S A Tomlins, et al.Arthritis and Rheumatism|July 1, 1993
Biopsychosocial contributions to the management of arthritis disability. Blueprints from an NIDRR-sponsored conferenceJ C Parker, L A Bradley, R M DeVellis, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
The use of 3-D dose volume analysis to predict radiation hepatitisT S Lawrence, R K Ten Haken, M L Kessler, et al.Pageof 17